uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted August 16, 2006

Marketers of Diabetes Supplement Banned From Claiming Products Treat or Cure Diseases

On August 10, 2006, the Federal Trade Commission (FTC) announced that an operation selling Chinese herbal supplements is banned from claiming its products treat or cure diseases, to settle FTC charges it violated a previous court order. The FTC alleged the sellers of Dia-Cope, a pill claimed to prevent, treat, and cure diabetes, violated the order by misrepresenting the health benefits of their product and misrepresenting that clinical trials proved their claims. The defendants will give up their ill-gotten gains – all of the assets they received from the sale of Dia-Cope.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at